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Abstract
Background Individuals coinfected with both hepatitis C virus (HCV) and HIV represent a unique and growing population of patients undergoing orthopaedic surgical procedures. Data regarding complications for HCV monoinfection or HIV monoinfection are robust, but there are no data available, to our knowledge, on patients who have both HCV and HIV infections. Questions/purposes We sought to determine whether patients with coinfection differed in terms of baseline demographics and comorbidity burden as compared with patients without coinfection and whether these potential differences were translated into varying levels of postoperative complications, mortality, and hospital readmission risk. Specifically, we asked: (1) Are there demonstrable differences in baseline demographic variables between patients infected with HCV and HIV and those who do not have those infections (age, sex, race, and insurance status)? (2) Do patients with HCV and HIV infection differ from patients without those infections in terms of other medical comorbidities? (3) Do patients with HCV/HIV coinfection have a higher incidence of early postoperative complications and mortality than patients without coinfection? (4) Is the frequency of readmission greater for patients with HCV/HIV coinfection than those without? Methods The New York Statewide Planning and Research Cooperative System (SPARCS) database was used to identify patients undergoing THA between 2010 and 2014. The SPARCS database is particularly useful because it captures 100% of all New York State inpatient admissions while providing detailed demographic and comorbidity data for a large, heterogeneous patient population with long-term followup. Patients were stratified into four groups based on HCV/HIV status: control patients without disease, HCV monoinfection, HIV monoinfection, and coinfection. We sought to determine whether patients coinfected with HCV and HIV would differ in terms of demographics from patients without those infections and whether patients with HCV and HIV would have a greater risk of complications, longer length of stay, and hospital readmission. A total of 80,722 patients underwent THA between 2010 and 2014. A total of 98.55% (79,554 of 80,722) of patients did not have either HCV or HIV, 0.66% (530 of 80,722) had HCV monoinfection, 0.66% (534 of 80,722) HIV monoinfection, and 0.13% (104 of 80,722) were coinfected with both HCV and HIV. Multivariate analysis was performed controlling for age, Each author certifies that neither he, nor any member of his immediate family, has funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article. All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request. Each author certifies that his institution waived approval for the human protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research.
sex, insurance, residency status, diagnosis, and comorbidities to allow for an equal comparison between groups. Results Patients with coinfection were more likely to be younger, male (odds ratio [ Conclusions As the prevalence of HCV and HIV coinfectivity continues to increase, orthopaedic surgeons will encounter a greater number of these patients. Awareness of the demographic and socioeconomic factors leading to increased complications after THA will allow physicians to consider interventions such as in-hospital psychiatric counseling, advanced discharge planning, and coordination with social work and collaboration with HCV/HIV infectious disease specialists to improve patient health status to improve outcomes and reduce costs. Level of Evidence Level III, therapeutic study.
Introduction
G lobally, nearly 35 million individuals are infected with HIV with recent estimates suggesting a 0.3% prevalence rate in North America and western Europe [39] . Hepatitis C virus (HCV) infection rates are higher with approximately 1.1% of people affected worldwide [24] . The high proportion of patients who have both HCV and HIV (defined as patients with coinfection) has been well documented [39, 53, 61] with estimates suggesting 25% to 30% of patients with HIV also have HCV [1] with coinfectivity prevalence rising as high as 90% in those who engage in IV drug use [23, 52, 61] .
There is an increased risk of perioperative complications associated with HCV and HIV monoinfection in the orthopaedic setting [6, 50] . To our knowledge, however, no study has yet examined the rate of perioperative complications and readmissions after THA in patients coinfected with both HCV and HIV. With recent reports suggesting the odds of acquiring HCV infection in HIV-positive individuals increased 4% per year between 2002 and 2013 [8] and that patients coinfected with both HCV and HIV demonstrate a faster rate of progression to liver fibrosis along with increased mortality than patients without coinfection [54] , it is important to better understand this unique population of patients within the context of orthopaedic surgical procedures.
The purpose of our study was to determine the impact that HCV and HIV coinfectivity had in patients undergoing elective THA. We therefore sought to determine whether patients coinfected with HCV and HIV would differ in terms of demographics from patients without those infections and whether patients with HCV and HIV would have a greater risk of complications, longer length of stay, and hospital readmission. Specifically, we asked: (1) Are there demonstrable differences in baseline demographic variables between patients infected with HCV and HIV and those who do not have those infections (age, sex, race, and insurance status)? (2) Do patients with HCV and HIV infection differ from patients without those infections in terms of other medical comorbidities? (3) Do patients with HCV/HIV coinfection have a higher incidence of early postoperative complications and mortality than patients without coinfection? (4) Is the frequency of readmission greater for patients with HCV/HIV coinfection than those without?
Patients and Methods
The New York Statewide Planning and Research Cooperative System (SPARCS) database was queried to identify patients 18 years of age and older who underwent elective inpatient THA. Numerous peer-reviewed publications have used SPARCS for epidemiologic studies in orthopaedics [20, 30, 41, 57, 62] . The SPARCS database captures 100% of all New York State inpatient admissions while providing detailed demographic and comorbidity data. A unique patient identifier allows patients to be longitudinally followed forward in time for as long as they are living and/or residents of New York State. For the purposes of our study, SPARCS provided a large, heterogeneous sample of patients undergoing THA in a variety of hospital settings across a contemporary time period. Because the SPARCS database contains deidentified information with no protected health information, we were exempt from institutional review board approval.
We identified patients between years 2010 and 2014 to provide a large sample representative of the most recent trends in THA while also being reflective of the increased availability and access to highly active antiretroviral therapy (HAART) [64] and HCV antivirals [53] .
International Classification of Diseases, 9
th Revision (ICD-9) code 81.51 was used to identify patients undergoing THA. To best identify an elective cohort, patients with fracturerelated diagnoses and those with evidence of malignancy were excluded [47] . Similar to previous methodology, all patients undergoing revision surgery for prior infection or previous surgical complications were excluded [34] as were those undergoing simultaneous bilateral THA. The primary diagnosis at the time of initial THA was stratified into two groups: primary osteoarthritis or avascular necrosis (AVN), whereas patients with other diagnoses (rheumatoid arthritis, posttraumatic arthritis) were excluded.
Similar to previous studies, a series of ICD-9 codes were used to identify patients with hepatitis C (070.41, 070.51, 070.44, 070.54, 070.70, and 070.71) [27] . Previous authors have commented on the accuracy of this algorithm, noting the absence of these ICD-9 codes has a negative predictive value ranging from 90% to 93% [16, 27, 32, 48] . HIV was similarly identified using previously utilized ICD-9 codes (042, 795.71, V08) [28, 36, 44] . Concomitant medical comorbidities were identified using the Elixhauser Comorbidity Criteria, which have been previously validated in orthopaedic database studies [43] . Excluding HCV and HIV, all comorbidities were summed with overall comorbidity burden stratified into four groups: zero, one, two, and three or more comorbidities. ICD-9 code 305.1 was used to identify patients with a history of tobacco use [38, 46, 58] . Patients were stratified into four groups to determine their overall HCV or HIV disease burden: absence of both HCV and HIV; monoinfection with HIV; monoinfection with HCV; and those coinfected with both HCV and HIV. Patients without either HIV or HCV served as our controls and those with any combination of HCV and/or HIV were compared with this control group.
Demographic information regarding patient age, sex, race, and insurance was collected. Because the SPARCS database provides a binary variable indicating whether the patient is homeless, patients were collapsed into two groups (homeless or not homeless) to determine the potential association of this factor on study outcomes.
The SPARCS database provides a unique encrypted patient identifier that can be used to longitudinally track all patients for all-cause hospital readmissions; this unique identifier has been utilized in numerous studies [4, 37, 41, 57] . Using this unique encrypted patient identifier, all patients were analyzed for the occurrence of hospital readmission within 90 days of discharge from the index THA with the primary ICD-9 diagnosis at the time of readmission serving as the etiology for readmission. This database was used to determine differences regarding hospital length of stay (LOS; days), discharge disposition (homebound versus skilled nursing facility), in-hospital complications, and in-hospital mortality. Hospital LOS was analyzed as both a continuous and binary variable (extended LOS) defined as a LOS greater than or equal to the 90 th percentile of all patients.
Statistical Analysis
For continuous variables, one-way analysis of variance was performed to determine if a difference between cohorts existed with subsequent utilization of pairwise comparisons to determine specific between-group differences. Because the data had a Gaussian distribution, mean values with SDs were calculated. Chi-square analysis and/or Fisher's exact test was used for categorical variables, and multivariate logistic regression was performed to provide odds ratios within a 95% confidence interval. Similar to previous studies using large registries, only variables present in at least 2% of the population were utilized for the multivariate analysis [5, 7, 33] . A stepwise regression model was used for purposes of analysis. Covariates included in the multivariate analysis were age, sex, race, insurance, HCV/HIV status, congestive heart failure, arrhythmia, valvular heart disease, hypertension, chronic lung disease, diabetes mellitus, hypothyroidism, chronic renal failure, rheumatoid arthritis, coagulation deficiency, obesity, chronic anemia, depression, obstructive sleep apnea, and tobacco use. SAS 9.3 (Cary, NC, USA) was used for data collection and statistical analyses with p values < 0.05 were considered statistically significant. Institutional review board approval was not required because human subject research was not performed. Patients with HIV, HCV, and coinfection had a higher preoperative comorbidity burden than control noninfected patients for almost all of the comorbidities we examined ( 
Results

Demographics of Patients
In-hospital Complications and Death
When all types of postoperative complications were considered, patients with coinfection were substantially more likely to experience complications than those with single infections and than those patients with no infection. Patients with coinfection had a 5% prevalence (OR, 3.55; 3.10-4.98; p < 0.001) of acute kidney injury as compared with 1% for control patients, (Table 3) .
Overall in-hospital mortality was higher in HCV-monoinfected patients (OR, 9.45; 8.84-11.65; p = 0.044), but not in patients with HIV monoinfection or coinfection, than for control patients after THA. Homebound discharge disposition did not vary widely among groups. Mean LOS after THA followed an incremental trend in our cohort. The shortest stays were observed for control patients with steady increases in LOS observed as disease burden increased: control patients (3.4 6 1.9 days), HCV monoinfection (4.1 6 3.1 days; p < 0.001; OR, 1.32; 95% CI, 1.22-1.64), HIV monoinfection (4.0 6 2.5 days; p < 0.001; OR, 1.40; 95% CI, 1.26-1.59), and coinfection (5.0 6 3.7 days; p < 0.001; OR, 1.64; 95% CI, 1.39-2.01).
After controlling for baseline demographics and comorbidities, multivariate logistic regression (Table 4) found that compared with patients without HCV or HIV, those with HCV/ HIV coinfection were at increased odds for having extended LOS (OR, 1.97; 95% CI, 1.29-3.01; p < 0.001) and two or more in-hospital complications (OR, 1.64; 1.01-2.67; p < 0.001). Discharge disposition did not follow this pattern because coinfected patients did not demonstrate greater odds of nonhomebound discharge than control patients (OR, 1.12; 95% CI, 0.74-1.71; p = 0.71).
Is the Incidence of Readmission Different for Patients With HCV/HIV Coinfection Than Those Without?
The 90-day readmission rate for control patients was 6.20% with higher rates observed in those with HCV monoinfection (11%; OR, 1.90; 1.45-2.64; p < 0.001), HIV monoinfection (17%; OR, 2.52; 2.09-3.11; p < 0.001), and highest in those with coinfection (24%; OR, 2.97; 1.86-4.77; p < 0.001).
Compared with control patients, patients with HCV or HIV monoinfection or coinfection were readmitted at much higher rates for alcoholor drug-related issues and for psychiatric disorders (Table 5) . Patients with coinfection were much more likely to be readmitted for sepsis than control patients (OR, 3.64; 2.83-4.22; p < 0.001). Interestingly, 8% of patients with coinfection who were readmitted were the result of hepatobiliary complications as compared with only 0.89% of healthy patients (OR, 7.22; 6.09-8.37; p < 0.001). Overall, control patients were readmitted more often for procedure-related complications than those with HCV or HIV monoinfection or coinfection, whereas those with HCV, HIV, or both conditions were more often readmitted as a result of medical etiologies.
Discussion
HIV and HCV coinfection rates are increasing, and orthopaedic surgeons continue to encounter a larger volume of patients within this population. We analyzed 80,722 patients to determine whether baseline differences existed between patients with coinfected, monoinfection, and controls and how these potential differences translated into in-hospital complications, LOS, discharge disposition, mortality, and readmission rates. We found that patients undergoing THA with HCV or HIV monoinfection or coinfection were younger, more likely to be men, of minority racial status, and insured by Medicaid as compared with control patients. In addition, patients with disease had a higher prevalence of most major medical comorbidities than control patients, particularly alcohol, drug, and tobacco use and psychiatric disorder diagnoses. This resulted in HCVand/or HIV-infected patients having higher in-hospital complications, longer LOS, greater hospital charges, and higher 90-day hospital readmission rates than patients without either HCV or HIV.
Our study has limitations inherent to database studies [42] . Errors in ICD-9 coding could potentially result in over-or underreporting of outcomes. The New York State Department of Health, however, seeks to minimize coding errors through a combination of laws that mandate 100% hospital compliance with submission of patient data and an auditing process that requires both hospitals and SPARCS database administrators to verify data Patients without HIV and HCV served as a reference for all statistical comparisons. HCV = hepatitis C virus; DVT = deep vein thrombosis; GU = genitourinary; ARDS = acute respiratory distress syndrome; SNF = skilled nursing facility; LOS = length of stay.
reporting. Additionally, we were unable to comment on viral loads of HCV and/or HIV in affected patients, viral genotype, and also whether patients were actively receiving HAART or HCV antiretroviral therapy at the time of THA. Although these data would be very useful, they are often difficult to capture in patients with coinfection as a result of access to care and socioeconomic factors that preclude regular testing and, although possibly reportable in small case series, were not quantifiable within the contexts of our large database study. Furthermore, the hospitals where care was provided to patients with infection and coinfection may have differed from hospitals where control patients were seen in size, location, or academic status. Finally, although our overall sample size was large, the low prevalence of HCV and HIV coinfection may have impeded our ability to identify statistical differences in certain calculations such as deep vein thrombosis and pulmonary embolism.
Demographic Differences
Patients without either HCV or HIV had a mean age of 65 years at the time of THA, whereas those coinfected were nearly 10 years younger (Table 1) . This younger age can be explained by our finding that patients with HIV monoinfection and coinfected patients had 38% and 42% of AVN as an etiology, respectively. Patients with AVN of the hip are usually younger than the "typical" patient with primary osteoarthritis [51, 55] and HIV and HAART are known risk factors for the development of AVN of the hip [40, 65] . Although HCV has not been reported as an independent risk factor for AVN, our observed 10% rate of AVN could be reflective of HCV-associated cryoglobulinemic vasculitis causing necrotic changes [12, 13] . The significant shift seen regarding women comprising the majority of control patients (56%) with men being the majority of recipients of THA as HCV and HIV disease burden increased is in agreement with previous literature stating that men make up 79% of patients with HIV and 54% of patients with HCV undergoing total joint arthroplasty [27, 34] . Our findings that minorities and Medicaid patients comprised the majority of patients coinfected with HCV and HIV is similarly substantiated by previous literature reports [6, 10, 27, 34, 47] . We reported that the rate of homelessness was nearly 14 times higher in coinfected patients compared with control patients (p < 0.001), a novel finding that highlights the importance of having an interdisciplinary team that can preoperatively identify socioeconomic factors unique to patients coinfected with HCV and HIV, thus allowing for appropriate discharge Patients without HIV and HCV served as a reference for all statistical comparisons; Miscellaneous orthopaedic = etiologies such as lumbago, ankle sprain, shoulder injuries; Miscellaneous medical = etiologies such as diabetes-related complications, thyroid disorders; Procedure-related complications = dislocation, revision; Infection = prosthesis-related infection; HCV = hepatitis C virus; DVT = deep vein thrombosis; PE = pulmonary embolism; GI = gastrointestinal; UTI = urinary tract infection.
planning and social support, which could increase the likelihood of improved outcomes.
Preoperative Comorbidity Burden
The examination of concomitant medical comorbidities found that alcohol abuse, drug abuse, and tobacco use were all notably higher in patients with HCV and/or HIV compared with control patients (Table 2) . Although this finding is noteworthy, it was perhaps more interesting to note that the observed incremental effect in coinfected patients demonstrated substantially higher rates of alcohol, drug, and tobacco use than in patients with HCV or HIV monoinfection. Again, we believe this finding highlights the importance of offering appropriate counseling and screening to these patients such as needle exchange programs, HCV treatment, and smoking cessation programs [11, 59] because cessation of high-risk activities and addressing modifiable risk factors before surgery cannot only improve perioperative outcomes, but may substantially improve quality of life along with reducing future morbidity and mortality. The higher incidence of psychiatric disorders and depression in patients with HCV and/or HIV has been well documented [27, 34] and represents another potential avenue for intervention. The significantly high prevalence of lung disease in HCVand/or HIV-infected patients is likely multifactorial and the result of the high rates of tobacco use in combination with mucociliary dysfunction and recurrent respiratory infections (HIV) [14, 17, 19] and lung fibrosis and obstructive lung disease (HCV) [26, 29, 45] . HCV can cause liver cirrhosis with resultant severe liver dysfunction [5, 6, 31, 63] . Although HIV monoinfection is not widely implicated as a primary etiology for liver failure, several authors report that coinfection with HIV results in a two to six times greater rate of progression to liver fibrosis as compared with HCV-monoinfected patients [15, 25, 32] . Furthermore, the liver is a vital organ that synthesizes the majority of clotting factors and proteins required for hemostasis [2, 35] , thus potentially explaining the substantially higher rates of coagulopathy observed in HCV-monoinfected and coinfected patients as compared with control patients and HIVmonoinfected patients, emphasizing the importance of performing these orthopaedic procedures in a hospital with critical care units and hepatologists available for optimal medical management.
Postoperative Complications
Our analysis revealed that the majority of postoperative complications occurred more frequently in HIV-monoinfected, HCV-monoinfected, and coinfected patients as compared with control patients. Our data parallel previous reports that HCV and HIV infection are associated with greater complications after THA [6, 10, 27, 34, 47] . Compared with control patients, risks of postoperative transfusion were highest in coinfected patients; postoperative hematoma/seroma followed a similar pattern. As previously mentioned, these findings could be reflective of the significantly higher rates of liver dysfunction and subsequent coagulopathy observed with HCV-monoinfected and coinfected patients. Additionally, certain anesthetic agents may accentuate liver dysfunction in the perioperative state, further worsening already pathologic decompensation, resulting in greater rates of postoperative ischemia and organ dysfunction [3, 21, 22] . This could explain why patients with coinfection had pulmonary complications and ARDS and required mechanical ventilation more frequently than control patients. Overall, the higher rates of various other complications are likely the result of the extremely complicated medical status of these patients. Multivariate analysis substantiated our findings and found that after controlling for baseline demographic and comorbidity differences, compared with control patients, patients with coinfection were at increased odds for LOS and total charges in the 90 th percentile along with having two or more in-hospital complications. Most notably, patients with coinfection had 2.97 odds of hospital readmission with 90 days of discharge as compared with control patients.
Although readmission rates were notably higher for all groups with either HCV or HIV, rates were highest in coinfected patients (24%). The significantly higher rates of sepsis seen in coinfected patients could be the result of their severely immunocompromised status, whereas psychiatric readmissions are likely related to high baseline levels of depression, psychiatric disease, substance abuse, and socioeconomic status unique to this population. Nearly 8% of all coinfected patients who were readmitted were secondary to hepatobiliary etiologies, which could be the result of a combination of liver dysfunction and medication side effects resulting in higher rates of gallstones and pancreatitis in this group [18, 49, 56, 60] . Although most control patients were readmitted for procedure-related complications, those patients coinfected or monoinfected with HCV or HIV tended to be readmitted for medical complications, again highlighting the importance of medical optimization in this subgroup before they undergo THA.
The combination of the increasing incidence of HCV and HIV coinfectivity along with the improved efficacy and increased access to antiviral drugs to treat these conditions will likely lead to increased demand for THA in this unique population of patients. Perioperative care plans should acknowledge that these patients often have many medical comorbidities and vastly different socioeconomic considerations than patients without HIV or HCV, which place them at risk for increased LOS and more frequent in-hospital complications and readmissions. Interventions such as in-hospital psychiatric counseling, advanced discharge planning and coordination with social work, and collaboration with HCV/HIV infectious disease specialists may be warranted [9] . Initiatives such as the NYSDOH Hepatitis C Testing Law will help reduce underdiagnoses of affected patients, allowing for early intervention and appropriate guidance. As pharmaceutical treatment for HCV continues to progress, treatment paradigms for HCV-or HIV-monoinfected and coinfected patients will continue to develop. Finally, knowledge that the coinfection rate is rising and portends negative consequences could inform future research in the direction of both improved pharmacologic management of patients with disease in consort with clinical and societal based efforts to prevent coinfection.
